Skip to main content
. 2016 Jan 28;6:310. doi: 10.3389/fphar.2015.00310

FIGURE 6.

FIGURE 6

Involvement of JNK1/2 in TNF-α-induced VCAM-1 expression in HCFs. (A) HCFs were pretreated with SP600125 (0.1, 1, or 10 μM) for 1 h, and then incubated with TNF-α for 16 h. The protein levels of VCAM-1 were determined by Western blot. (B) HCFs were pretreated with SP600125 (10 μM) for 1 h, and then incubated with TNF-α for 4 h. The mRNA expression (white bar) and promoter activity (gray bar) of VCAM-1 were determined by real-time PCR or promoter report assay, respectively. (C) HCFs were pretreated with SP600125 (10 μM) for 1 h, and then incubated with TNF-α for the indicated time intervals. The levels of phospho-JNK1/2 were determined by Western blot. (D) HCFs were transfected with either scrambled or JNK1 siRNA, and then incubated with TNF-α for 16 h. The levels of JNK1 and VCAM-1 protein were determined by Western blot. (E) HCFs were pretreated without or with TNFR nAb (10 μg/ml), Gö6976 (10 μM), edaravone (10 μM), or DPI (10 μM) for 1 h, and then incubated with TNF-α for the indicated time intervals. The levels of phospho-JNK1/2 were determined by Western blot. Data are expressed as mean ± SEM of three independent experiments (n = 3, Quantitative data of Figures 6C–E were presented in Supplementary Table S2). #P < 0.01, as compared with the cells exposed to TNF-α alone.